基本情報
- 所属
- 自治医科大学 医学部外科学講座 消化器一般移植外科学部門 主任教授 (附属病院 病院長)(兼任)病院長
- 学位
- 医学博士(東京大学)
- J-GLOBAL ID
- 200901010372664634
- researchmap会員ID
- 1000300013
経歴
8-
2003年8月 - 2007年9月
-
2000年4月 - 2003年7月
-
2000年 - 2002年
-
1994年1月 - 1996年9月
-
1994年 - 1996年
学歴
2-
- 1984年
-
- 1984年
委員歴
10-
2018年 - 現在
-
2018年 - 現在
-
2000年 - 現在
-
2000年 - 現在
-
1997年 - 現在
論文
556-
日本胃癌学会総会記事 95回 459-459 2023年2月
-
日本腹部救急医学会雑誌 43(2) 359-359 2023年2月
-
BJS open 7(1) 2023年1月6日BACKGROUND: Low-density granulocytes (LDGs) have been shown to be increased in the peripheral blood of patients with inflammatory and malignant diseases. This study evaluated LDGs in patients who underwent radical surgery for colorectal cancer (CRC) and their impact on survival. METHODS: Patients who underwent radical colectomy between 2017 to 2021 were screened for enrolment in the study. Peripheral blood was obtained in the operating room before and after surgery and cells were recovered from the mononuclear layer after density gradient preparations. The ratio of CD66b(+) LDG to CD45(+) leukocytes was determined with flow cytometry, and the association of the ratios with patient outcomes was examined. The main outcome of interest was recurrence-free survival (RFS). RESULTS: Out of 228 patients treated, 176 were enrolled, including 108 colonic and 68 rectal cancers. Overall, 38 patients were stage I, 30 were stage II, 72 were stage 3, and 36 were stage IV. The number of LDGs was markedly increased immediately after surgery and the proportion of LDGs correlated positively with operating time (r = 0.2806, P < 0.001) and intraoperative blood loss (r = 0.1838, P = 0.014). Purified LDGs produced high amounts of neutrophil extracellular traps after short-term culture and efficiently trapped tumour cells in vitro. The proportion of postoperative LDGs was significantly higher in 13 patients who developed recurrence (median 9 (range 1.63-47.0)) per cent versus median 2.93 ((range 0.035-59.45) per cent, P = 0.013). When cut-off values were set at 4.9 per cent, a higher proportion of LDGs was strongly and independently associated with decreased RFS (P = 0.005). In patients with stage III disease, adjuvant chemotherapy significantly improved RFS of patients with high ratios of LDGs, but not low LDGs. CONCLUSION: LDGs are recruited to circulating blood by surgical stress early in the postoperative interval after colectomy for colonic cancer and their postoperative proportion is correlated with recurrence.
-
臨床消化器内科 38(2) 165-170 2023年1月<文献概要>膵癌早期診断研究会(JEDPAC)でStage 0とStageI膵癌の臨床的な特徴をまとめた.危険因子に関しては,糖尿病やIPMNなどを合併している患者が多かった.受診契機は,他疾患の経過観察中に発見された症例が最も多く症状のない症例が多かった.画像所見に関して,膵管拡張などの副所見が指摘された症例が多かった.また,早期に診断される膵癌の特異的な画像所見として認識されつつある膵の限局的脂肪化は約40%の症例に認められた.また,Stage 0の症例はENPDによる膵液細胞診によって病理学的に診断された症例が多かった.Stage 0とStageIの膵癌の予後は良好であったが,残膵癌に注意する必要があることが明らかになった.さまざまな臨床的な特徴を踏まえ,膵癌が早期に診断され,予後の改善に結びつくことが期待される.
-
Islets 14(1) 69-81 2022年12月31日
-
日本小児外科学会雑誌 58(7) 1011-1016 2022年12月自己肝温存胆道閉鎖症の長期経過観察中に肝内胆管癌を認めた1例を報告する.25歳男性.日齢78にIII-a1-vの胆道閉鎖症に対して逆流防止弁付き肝門部空腸吻合術を施行した.21歳時に超音波検査で肝右葉に嚢状肝内胆管拡張を認め,bile lakeとして経過観察した.25歳時に黄疸を伴う胆管炎と肝膿瘍を疑う病変を認め,小腸内視鏡を施行し,逆流防止弁の狭窄解除を行ったが,肝門部空腸吻合部に到達できなかった.難治性胆管炎にて肝移植を考慮され,当科紹介となった.当科受診時のCA19-9が7,092U/mlと高値であり,肝右葉の腫瘍性病変に対して生検を施行し,肝内胆管癌stage IVB(腹膜播種)と診断した.門脈浸潤に対して経皮経肝的ステント留置を行い,化学療法を施行したが,化学療法開始11ヵ月時に十二指腸浸潤の消化管出血で死亡した.胆道閉鎖症の長期管理に悪性腫瘍のスクリーニングは必須である.(著者抄録)
-
Pediatric transplantation 26(8) e14402 2022年12月BACKGROUND: Repeat liver transplantation (LT) for patients with the liver graft failure who underwent metallic stent placement in the previous graft hepatic vein (HV) for HV complications can be very difficult. We retrospectively reviewed the safer surgical procedures during repeat LT for patients with a metallic stent in the graft HV. CASE REPORTS: Patient 1 with biliary atresia who was treated with metallic stent placement for HV stenosis underwent a third LT form a deceased donor at the age 17 years. Patient 2 with ornithine transcarbamylase deficiency who was treated with metallic stent placement for refractory HV stenosis underwent a second LT form a deceased donor at age 9 years. In both patients, transection of the previous graft HV through an intraabdominal approach was difficult during repeat LT, and a supradiaphragmatic inferior vena cava (IVC) approach was introduced. Using a midline incision of the diaphragm, the pericardium was incised and the supradiaphragmatic IVC was encircled. After clamping the supradiaphragmatic IVC, graft hepatectomy was performed. The metallic stent was successfully removed breaking, and HV reconstruction was performed on the suprahepatic IVC. Both patients did well without serious HV complications after repeat LT. CONCLUSIONS: The surgical technique for the supradiaphragmatic IVC approach is useful to decrease the risk of fatal operative complications during repeat LT for patients with a metallic stent in the graft HV.
-
World Journal of Gastroenterology 28(38) 5614-5625 2022年10月14日
-
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 24(10) 1140-1149 2022年10月AIM: The clinical efficacy of chemoradiotherapy (CRT) is largely dependent on host immune status. The aim of this study was to identify possible markers expressed on circulating mononuclear cells to predict tumour response in patients with locally advanced rectal cancer (LARC). METHODS: Peripheral blood samples were obtained from 47 patients diagnosed with LARC before and after CRT. The numbers of lymphocytes and monocyte subsets were analysed using flow cytometry. Based on clinical and pathological findings, patients were classified as high or low responders. RESULTS: Lymphocyte counts were markedly decreased after CRT. Total numbers of lymphocytes (p = 0.030) and CD4(+) T cells (p = 0.041) in post-CRT samples were significantly lower in low responders than in high responders. In contrast, monocyte counts were not reduced and the number of CD14dim (+) CD16(+) nonclassical (patrolling) monocytes were somewhat increased after CRT (p = 0.050). Moreover, the ratios of programmed cell death ligand 1 (PD-L1) (+) cells on patrolling monocytes before and after CRT were significantly higher in low responders than in high responders (p = 0.0046, p = 0.0006). The same trend was observed for classical and intermediate monocytes. The expression of PD-L1 on patrolling monocytes before CRT correlated inversely with the number of T cells and natural killer (NK) cells after CRT. PD-L1(+) ratio in patrolling monocytes was an independent predictor for response to CRT. CONCLUSION: Programmed cell death ligand 1 (PD-L1) expression on patrolling monocytes suppresses cell-mediated immunity in patients receiving CRT which could be related to tumour response, and may be a useful biomarker for decision-making in the management of patients with LARC.
-
日本癌治療学会学術集会抄録集 60回 OWS35-7 2022年10月
-
Journal of gastroenterology 57(10) 709-724 2022年10月BACKGROUND: Chronic pancreatitis (CP) is defined according to the recently proposed mechanistic definition as a pathological fibro-inflammatory syndrome of the pancreas in individuals with genetic, environmental, and/or other risk factors who develop persistent pathological responses to parenchymal injury or stress. METHODS: The clinical practice guidelines for CP in Japan were revised in 2021 based on the 2019 Japanese clinical diagnostic criteria for CP, which incorporate the concept of a pathogenic fibro-inflammatory syndrome in the pancreas. In this third edition, clinical questions are reclassified into clinical questions, background questions, and future research questions. RESULTS: Based on analysis of newly accumulated evidence, the strength of evidence and recommendations for each clinical question is described in terms of treatment selection, lifestyle guidance, pain control, treatment of exocrine and endocrine insufficiency, and treatment of complications. A flowchart outlining indications, treatment selection, and policies for cases in which treatment is ineffective is provided. For pain control, pharmacological treatment and the indications and timing for endoscopic and surgical treatment have been updated in the revised edition. CONCLUSIONS: These updated guidelines provide clinicians with useful information to assist in the diagnosis and treatment of CP.
-
Surgery (United States) 172(3) 962-967 2022年9月Background: The number of total pancreatectomy cases have increased worldwide, expanding the need for new insulin products and high-titer pancrelipases. However, the current data that is focused on hypoglycemic events after a total pancreatectomy from large nationwide series are still lacking. This study is aimed to assess the risk factors associated with hypoglycemic events after a total pancreatectomy. Methods: Data were prospectively collected from 216 consecutive patients who underwent total pancreatectomies between August 2015 and December 2017 from 68 Japanese centers. Of the 216 patients, 166 with a follow-up period of 1 year were analyzed. The risk factors for hypoglycemic events at 6 and 12 months (postoperative months 6 and 12) were investigated based on the results of a nationwide multicenter prospective study. Results: Of the 166 patients, 57 (34%) and 70 (42%) experienced moderate or severe hypoglycemic events or hypoglycemia unawareness on a monthly basis at postoperative months 6 and 12, respectively. Multivariate analysis revealed that body weight loss after surgery ≥0.3 kg and total cholesterol level ≤136 mg/dL at postoperative month 6, and glycated hemoglobin level ≤8.9% and rapid-acting insulin use at postoperative month 12 were independent risk factors for hypoglycemic events after a total pancreatectomy. There were different independent risk factors depending on the postoperative period. Conclusion: Patients with body weight loss after surgery, low total cholesterol level, strict glycemic control, and using rapid-acting insulin should be aware of the occurrence of hypoglycemic events after their total pancreatectomy. In order to prevent hypoglycemic events after a total pancreatectomy, we need to consider optimal nutritional and glycemic control according to the postoperative period.
-
日本病院薬剤師会雑誌 58(9) 1024-1028 2022年9月肝移植領域でのエベロリムス(EVR)の使用経験例は少ない。またEVRは移植臓器である肝臓で代謝されることに加えて、初期投与量設定に用いる指標がないため速やかに目標血中濃度に到達させるのが難しい現状がある。今回、タクロリムス(Tac)の薬物動態に基づいたEVRの初期投与量設計の可能性を見出すため、自治医科大学附属病院におけるEARとTacの薬物動態の相関関係を検討した。方法として、EVRとTacの血中濃度(ng/mL)を1日投与量(mg/day)で除したC/D比を算出し、相関関係を後方視的に検討した。結果は患者間でEVRの1日投与量と血中濃度の相関関係はなく(r=0.3615、p=0.169)、EARとTacのC/D比に正の相関関係が得られた(r=0.7472、p<0.001)。肝移植症例におけるTacとEVRの薬物動態には相関関係があるため、今後、EVR投与量設計の参考になると思われた。(著者抄録)
-
日本癌学会総会記事 81回 SST3-6 2022年9月
-
Heliyon 8(8) e10303-e10303 2022年8月
-
胆と膵 43(7) 685-690 2022年7月肝移植後胆道合併症は依然として発症率が高く、予後に影響する重要な合併症である。胆道合併症は胆管狭窄、胆汁瘻に大別されるが、肝内結石はまれであり、とくに小児肝移植後肝内結石の診断・治療は確立されていない。小児肝移植症例の胆道再建は胆管空腸吻合がほとんどであるため、胆道合併症に対する治療は経皮経肝的胆道ドレナージ(PTBD)下カテーテル治療か外科的治療に限られていた。近年、ダブルバルーン小腸内視鏡(DBE)の改良とデバイスの進歩により、小児肝移植後胆道合併症においてもDBE下カテーテル治療が可能になってきている。低侵襲治療であるDBE下治療により、小児肝移植後肝内結石に対しても早期発見治療が可能となり、今後長期予後の向上が期待できる。(著者抄録)
-
Laparoscopic surgical skill evaluation with motion capture and eyeglass gaze cameras: A pilot study.Asian journal of endoscopic surgery 15(3) 619-628 2022年7月INTRODUCTION: An eyeglass gaze camera and a skeletal coordinate camera without sensors attached to the operator's body were used to monitor gaze and movement during a simulated surgical procedure. These new devices have the potential to change skill assessment for laparoscopic surgery. The suitability of these devices for skill assessment was investigated. MATERIAL AND METHODS: Six medical students, six intermediate surgeons, and four experts performed suturing tasks in a dry box. The tip positions of the instruments were identified from video recordings. Performance was evaluated based on instrument movement, gaze, and skeletal coordination. RESULTS: Task performance time and skeletal coordinates were not significantly different among skill levels. The total movement distance of the right instrument was significantly different depending on the skill level. The SD of the gaze coordinates was significantly different depending on skill level and was less for experts. The expert's gaze stayed in a small area with little blurring. CONCLUSIONS: The SD of gaze point coordinates correlates with laparoscopic surgical skill level. These devices may facilitate objective intraoperative skill evaluation in future studies.
-
Pancreas 51(6) 678-683 2022年7月
-
Journal of Hepato-Biliary-Pancreatic Sciences 2022年7月
-
Heliyon 8(6) e09730 2022年6月PURPOSE: Although neutrophil extracellular traps (NETs) are present in various tumors, their roles in tumor biology have not been clarified yet. In this study, we examined how NETs affect the pharmacokinetics and effects of doxorubicin (DOX). METHODS: NETs were generated by neutrophils stimulated with phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS). DOX was added to NETs and their distribution was observed under fluorescein microscopy, and the diffusion of DOX through 3 μM pores from lower to upper chambers was evaluated with a fluorescence-based assay. Ovarian cancer cells, KOC-2S and SKOV3, were embedded in collagen gel droplets and cultured in 3D way and their apoptosis was examined with flow cytometry. RESULTS: DOX was mostly co-localized with NETs. The transfer of DOX to upper chambers increased over time, which was significantly decreased by the presence of neutrophils stimulated with PMA or LPS in the lower chamber. DOX outside of the gel increased the rates of annexin V (+) apoptotic cells, which were significantly reduced by the addition of LPS-stimulated neutrophils in media both in KOC-2S and SKOV3. The reduced diffusion and apoptosis were mostly restored by the destruction of the NETs structure with 1000 u/ml DNAse I. CONCLUSION: NETs efficiently trap and inhibit the diffusion of DOX which may attenuate its ability to induce apoptosis of ovarian cancer cells. Degradation of NETs with DNAse I may augment the response of ovarian cancer to DOX.
MISC
516-
CANCER RESEARCH 83(7) 2023年4月
-
PANCREAS 51(6) 711-711 2022年7月
講演・口頭発表等
975-
日本消化器外科学会総会 2021年7月 (一社)日本消化器外科学会
所属学協会
10-
2000年 - 現在
-
1999年 - 現在
-
1999年 - 現在
-
1997年 - 現在
-
1991年 - 現在
共同研究・競争的資金等の研究課題
17-
日本学術振興会 科学研究費助成事業 2023年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 2023年6月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 2022年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2020年4月 - 2023年3月
-
日本学術振興会 科学研究費助成事業 挑戦的研究(萌芽) 2018年6月 - 2021年3月